Cardiac Biotech Solutions Inc.

Cardiac Biotech Solutions Inc. financial statements

Cardiac Biotech Solutions Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2026

RevenueUSD 152.73KEODHD
Net income−USD 895.97KEODHD
Cash and equivalentsUSD 3.86KEODHD
Total debtUSD 537.5KEODHD

Cardiac Biotech Solutions Inc. financials on 6ix · Cardiac Biotech Solutions Inc. on 6ix